Engineering NK-92 Cell by Upregulating CXCR2 and IL-2 Via CRISPR-Cas9 Improves Its Antitumor Effects as Cellular Immunotherapy for Human Colon Cancer
2021 ◽
Vol 41
(12)
◽
pp. 450-460
Keyword(s):
2011 ◽
Vol 193
(1)
◽
pp. 43-49
◽
Keyword(s):
2015 ◽
Vol 23
(3)
◽
pp. 225-232
◽
Keyword(s):
2013 ◽
Vol 124
◽
pp. 78-87
◽
Keyword(s):
2012 ◽
Vol 50
(5)
◽
pp. 1271-1278
◽
Keyword(s):
2003 ◽
Vol 111
(1)
◽
pp. 63-69
◽
Keyword(s):
Keyword(s):